Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
Medical experts reveal why miracle weight-loss drugs like Ozempic are failing to address the psychological roots of emotional eating, calling for integrated mental health support alongside pharmaceutical treatments.
Former Gogglebox favourite Amy Tapper opens up exclusively about her life-changing 10-stone weight loss journey using diabetes drug Mounjaro, sharing her struggles and triumphs.
A revolutionary new weight loss pill, Survodutide, is making waves in medical trials, with manufacturers boasting it could be twice as effective as blockbuster drugs like Ozempic and Wegovy.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
A groundbreaking new oral weight loss drug, Orforglipron, could rival Wegovy injections after a UK study showed participants lost over 10% of their body weight. Discover the potential game-changer for obesity treatment.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
Exclusive investigation reveals the alarming trend of unregulated weight-loss jabs like Retatrutide being promoted on TikTok, posing severe health risks to UK users desperate for quick fixes.
A landmark UNICEF report reveals a historic shift: ultra-processed foods have led to more children globally being obese than underweight for the first time, signalling a urgent public health crisis.
A British mother's life-changing journey from 30st to 8st using diabetes drug Mounjaro. Discover how this remarkable transformation saved her marriage and restored her health against all odds.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
Groundbreaking research from the UK reveals a specific brain cell that controls hunger impulses, paving the way for revolutionary obesity prevention and treatment strategies that could transform public health.
UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Exclusive investigation reveals the UK towns drowning in fast food, with Jaywick, Essex, crowned the nation's takeaway capital. Health experts sound the alarm on obesity crisis.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.
Former Culture Minister Ed Vaizey calls for VAT removal on prescription obesity drugs, arguing it would boost public health and reduce long-term NHS costs.
Supermarket giant Asda has dramatically cut the price of the sought-after weight loss drug Mounjaro, making the weekly injection more affordable for Brits seeking treatment.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.